Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
Related press release
VIRI similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement on Forms S-3 and S-8 (Nos. 333-263700, 333-265757, 333-251544) of Virios Therapeutics, Inc. of our report dated March 14, 2023, with respect to the financial statements of Virios Therapeutics, Inc. included in this Annual Report on Form 10-K for the year ended December 31, 2022.
/s/ FORVIS, LLP (Formerly, Dixon Hughes Goodman LLP)
Atlanta, Georgia
March 14, 2023